PHARM-LC: What role can Community Pharmacy play in supporting people with long Covid? Protocol for a mixed methods study [version 1; peer review: awaiting peer review]

Abstract

Background Long Covid is a debilitating multifaceted condition, that is more prevalent in those from deprived areas, females and those with another disorder or disability. Those that live with Long Covid currently must endure a lack of services, support and have also reported being ‘gaslit’ by health care professionals. Primary care services such as GP surgeries are under immense pressure and have limited resources to offer those that live with Long Covid. Community pharmacy could be a localised solution for those that need support and advice for Long Covid as they have already proven to be a reliable source during the COVID-19 pandemic. This study aims to address gaps in research to explore the possible role that community pharmacy teams can play in supporting those living with Long Covid. Protocol A two-phase multi-method study using semi-structured interviews and co-design will be utilised. For phase one: two population groups; those with lived experience of Long Covid and community pharmacy team members will be interviewed to understand their current experiences of community pharmacy supporting those living with Long covid, as well as lived experiences and self-management (people with Long Covid), and training needs, and current practice (Community pharmacy teams). For phase two: a co-design approach will be utilised with key stakeholders to help inform online training via multiple workshops. This training will be then piloted by end users, who will provide post training feedback via a survey. Discussion Understanding the role that community pharmacy can play in supporting those with Long Covid and to facilitate development of this new support pathway to develop online training which provides pharmacy teams with a structured and cohesive approach to care.

Publication DOI: https://doi.org/10.3310/nihropenres.13741.1
Divisions: College of Health & Life Sciences > Aston Pharmacy School
College of Health & Life Sciences
Aston University (General)
Funding Information: This study project is funded by the National Institute for Health and Care Research (NIHR ) under its [Research for Patient Benefit. NIHR: 205384.(Grant Reference Number NIHR205384)]. The views expressed are those of the author(s) and not necessarily thos
Additional Information: Copyright © 2024 Kingstone T et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Last Modified: 19 Dec 2024 08:24
Date Deposited: 12 Nov 2024 16:52
Full Text Link: https://openres ... rticles/4-65/v1
Related URLs:
PURE Output Type: Discussion paper
Published Date: 2024-10-21
Published Online Date: 2024-10-21
Accepted Date: 2024-10-01
Authors: Kingstone, Tom
Saunders, Katie
Fisher, Tamsin
Bhamra, Sukvinder
Briggs, Tracy
Higginbottom, Adele
Higginson, Paula
Jones, Geraint
Lokugamage, Amali
Maidment, Ian (ORCID Profile 0000-0003-4152-9704)
O'Hara, Margaret
Shaw, Matthew
Group, Pharm-LC Clinical Advisory
Chew-Graham, Carolyn

Download

[img]

Version: Published Version

License: Creative Commons Attribution

| Preview

Export / Share Citation


Statistics

Additional statistics for this record